Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B p50 Subunit | 7 | 2020 | 38 | 1.350 |
Why?
|
| NF-kappa B | 4 | 2021 | 423 | 0.690 |
Why?
|
| Genomic Instability | 2 | 2020 | 90 | 0.570 |
Why?
|
| DNA Damage | 4 | 2019 | 399 | 0.520 |
Why?
|
| S Phase | 1 | 2015 | 64 | 0.430 |
Why?
|
| DNA Replication | 1 | 2015 | 169 | 0.410 |
Why?
|
| Glioblastoma | 2 | 2021 | 300 | 0.250 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2019 | 136 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 314 | 0.230 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 843 | 0.200 |
Why?
|
| Phosphorylation | 3 | 2015 | 1145 | 0.190 |
Why?
|
| Binding Sites | 4 | 2021 | 1159 | 0.170 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 46 | 0.170 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 20 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 80 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 188 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2020 | 519 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 2894 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 132 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 978 | 0.130 |
Why?
|
| Serine | 2 | 2020 | 106 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 463 | 0.120 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2015 | 4 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2015 | 15 | 0.110 |
Why?
|
| Mice | 8 | 2020 | 12718 | 0.110 |
Why?
|
| Sialoglycoproteins | 1 | 2015 | 31 | 0.110 |
Why?
|
| Comet Assay | 1 | 2015 | 8 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2014 | 6 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 74 | 0.110 |
Why?
|
| Luciferases | 1 | 2015 | 128 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 139 | 0.110 |
Why?
|
| Dacarbazine | 1 | 2015 | 104 | 0.110 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 65 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2015 | 273 | 0.100 |
Why?
|
| DNA Primers | 1 | 2015 | 530 | 0.100 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 74 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 301 | 0.100 |
Why?
|
| RNA Interference | 1 | 2015 | 388 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2015 | 480 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 889 | 0.090 |
Why?
|
| Protein Binding | 2 | 2015 | 1557 | 0.090 |
Why?
|
| Nucleotides | 1 | 2012 | 93 | 0.090 |
Why?
|
| Animals | 10 | 2020 | 28950 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 3279 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 682 | 0.080 |
Why?
|
| DNA | 2 | 2014 | 1274 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 587 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2010 | 89 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2010 | 118 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 770 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2019 | 830 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 557 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2020 | 3627 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 850 | 0.070 |
Why?
|
| Cell Line | 1 | 2012 | 2482 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1133 | 0.070 |
Why?
|
| Alkylation | 2 | 2020 | 31 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 642 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 1717 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2011 | 734 | 0.060 |
Why?
|
| Base Sequence | 2 | 2021 | 2222 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2020 | 766 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2020 | 0.050 |
Why?
|
| Humans | 10 | 2021 | 98223 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1395 | 0.050 |
Why?
|
| Cell Death | 2 | 2014 | 258 | 0.040 |
Why?
|
| Cellular Senescence | 2 | 2014 | 111 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2020 | 80 | 0.040 |
Why?
|
| DNA Probes | 1 | 2020 | 66 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 170 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2020 | 67 | 0.040 |
Why?
|
| Lysine | 1 | 2020 | 170 | 0.040 |
Why?
|
| Apoptosis | 2 | 2015 | 1752 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 256 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 403 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3612 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2020 | 410 | 0.030 |
Why?
|
| Pyrazolones | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nitrobenzenes | 1 | 2015 | 12 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 10c | 1 | 2015 | 3 | 0.030 |
Why?
|
| Benzoates | 1 | 2015 | 34 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2015 | 58 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 68 | 0.030 |
Why?
|
| Gliosis | 1 | 2014 | 32 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2015 | 100 | 0.030 |
Why?
|
| Kyphosis | 1 | 2014 | 25 | 0.030 |
Why?
|
| Longevity | 1 | 2014 | 64 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 160 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 123 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 293 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2014 | 272 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 390 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 529 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Male | 4 | 2019 | 47195 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 364 | 0.020 |
Why?
|
| Glioma | 1 | 2015 | 309 | 0.020 |
Why?
|
| Female | 4 | 2020 | 51685 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 670 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1321 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4126 | 0.020 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 83 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 193 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1891 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1972 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2856 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 310 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2209 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 405 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2068 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1129 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2653 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1751 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 5573 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 2431 | 0.010 |
Why?
|